The mission of Dr. Timothy Durazzo's BRASS lab is to better understand how the interplay between biomedical, psychological and social factors influence treatment outcome in Veterans and civilians seeking treatment for alcohol and substance use disorders. To accomplish this mission, the multidisciplinary team integrates information from advanced neuroimaging, neurocognitive assessment, psychodiagnostic and genotyping methods to identify the biopsychosocial factors associated with relapse and sustained sobriety.

Dr. Yu Zhang's research operates at the intersection of AI, translational neuroscience, and precision medicine. His work focuses on unraveling the complex neurobiological mechanisms underlying cognitive deficits, behavioral dysfunctions, and therapeutic responses in mental health disorders. By integrating advanced machine learning techniques with multimodal brain imaging modalities (e.g., fMRI, DTI, EEG), Dr.

Dr. Miles Berger is a neuroanesthesiologist and translational human neuroscientist. Clinically, Dr. Berger cares for patients undergoing brain and spine surgery, and has an interest in optimizing anesthesia care (and postoperative cognitive outcomes) for older surgical patients. 

Dr. Sean Spencer is a Gastroenterologist and Physician Scientist at Stanford University working with Dr. Justin Sonennburg to uncover the role of dietary intake on the gut microbiome and mucosal immune system. Dr. Spencer obtained his medical degree University of Pennsylvania, earning his PhD studying nutritional immunology with Dr. Yasmine Belkaid at the National Institutes of Health (NIH), after which he moved to Boston for residency training at Massachusetts General Hospital and completed his Gastroenterology training at Stanford University. Dr.

Dr. Spyridon Karadimas is a board-certified, fellowship-trained cerebrovascular neurosurgeon and physician-scientist with Stanford Health Care. He is also an assistant professor in the Department of Neurosurgery at Stanford University School of Medicine.

Dr. Elizabeth Mayne's lab uses mouse models of pediatric stroke to study how brain injuries in childhood disrupt later neurodevelopment, with a long-term goal of developing treatments to prevent or reduce cognitive disability after pediatric stroke and other acquired brain injuries of childhood.

Dr. Sophia Wang is a trained glaucoma and cataract surgeon and clinician scientist performing research in artificial intelligence in ophthalmology. 

Dr. Peter Dahlberg received his undergraduate degree at McGill University in 2011 and his Ph.D. in biophysics from the University of Chicago in 2016. He then came to Stanford to work with W. E. Moerner and Wah Chiu to develop correlative light and electron microscopy methods. These methods give highly specific information on the machines that fill cells and make them work. In 2021 he was awarded SLAC’s Panofsky Fellowship to continue his work on correlative microscopy. In 2023 he transitioned to a Staff Scientist role at SLAC. 

As a neuroscientist and psychiatrist, Dr. Kevin Kelley is motivated by how little we understand about the pathophysiology of psychiatric disorders and hope that further knowledge will help to alleviate the ongoing distress of many of our patients. Dr. Kelley's research program leverages computational genomics, human brain cellular models, and molecular neuroscience techniques to understand the cellular and molecular mechanisms of human brain development and how dysfunction in these processes lead to psychiatric disorders.

Dr. Shoa Clarke is a preventive cardiologist and a physician-scientist focused on disease prevention. He earned his undergraduate degree in human biology from the Division of Nutritional Sciences at Cornell University before obtaining his MD and PhD (genetics) from Stanford University School of Medicine. He has completed clinical training in internal medicine (Brigham & Women’s Hospital), pediatrics (Boston Children’s Hospital), and cardiovascular medicine (Stanford Hospital), and he is board certified in all three specialties.